Clarify pharma plc
WebAbout Clarify Pharma PLC: Listed on the Aquis Stock Exchange in London, Clarify Pharma is an investment vehicle focusing on investing in biotech and life sciences companies seeking to prove the safety and efficacy of psychedelic-based substances.The Company looks to identify investment opportunities in the life sciences sector within the … WebClarify Pharma (AQSE:PSYC) ROIC % as of today (April 02, 2024) is 0.00%. ROIC % explanation, calculation, historical data and more
Clarify pharma plc
Did you know?
WebFinancial insights and latest news of Clarify Pharma Plc. Clarify seeks to develop a business concentrating on high potential and fast-growing biotech and life science … WebMar 2, 2024 · Clarify Pharma PLC does not have significant operations. It focuses on portfolio of clinical psychedelics companies. Clarify Pharma PLC was incorporated in 2024 and is based in London, the United Kingdom. Read more. Rewards. Risk analysis. Makes less than USD$1m in revenue (£0)
WebMay 5, 2024 · Press Release. 05 May 2024 Clarify Pharma PLC ("Clarify Pharma" or "The Company") Full Year Results Clarify Pharma (AQSE: PSYC), an investment vehicle specialising in biotech and life sciences companies seeking to prove the safety and efficacy of psychedelic-based substances, announces its audited financial results for the twelve … WebApr 5, 2024 · Clarify Pharma PLC (PSYC:NXX) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.
WebClarify Pharma (AQSE:PSYC) Shareholder Yield % as of today (April 02, 2024) is 0.00%. Shareholder Yield % explanation, calculation, historical data and more WebClarify Pharma Plc is listed on the Aquis Stock Exchange, trading with ticker code PSYC.PL. It has a market capitalisation of £0.00, with approximately 0.00 shares in issue. Over the last year ...
WebFinancial insights and latest news of Clarify Pharma Plc. Clarify seeks to develop a business concentrating on high potential and fast-growing biotech and life science companies that perform research or produce neuro-pharmaceutical drug development platforms. The focus will be on businessesthat advance medicines based on psychedelic …
WebMay 10, 2024 · Clarify Pharma, an investment vehicle specialising in biotech and life sciences companies seeking to prove the safety and efficacy of psychedelic-base Clarify … tpp gravidezWebFeb 15, 2024 · Clarify Pharma PLC is engaged in performing research or producing neuro-pharmaceutical drug development platforms that advance medicines through science … tpp kota cirebon 2021WebApr 5, 2024 · Clarify Pharma PLC (PSYC:NXX) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. Clarify … tpp global servicesWebClarify Pharma PLC (PSYC) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. tpp kobarWebAug 17, 2024 · Press Release 17 August 2024. Clarify Pharma PLC ("Clarify Pharma" or the "Company") First Capital Investment Made Clarify Pharma (AQSE: PSYC), an investment vehicle specialising in biotech and life sciences companies seeking to prove the safety and efficacy of psychedelic-based substances, is pleased to announce a maiden … tpp kota cirebonWebMay 10, 2024 · Clarify Pharma, an investment vehicle specialising in biotech and life sciences companies seeking to prove the safety and efficacy of psychedelic-based substances, is pleased to announce its intention to apply for admission of its Ordinary Shares to trading on the Access segment of Aquis Stock Exchange Growth Market … tpp graphWebMar 28, 2024 · As of last trade, Clarify Pharma PLC (PSYC:NXX) traded at 0.81, 24.62% above the 52 week low of 0.65 set on Nov 07, 2024. tpp oj no